210.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VEEV Giù?
Forum
Previsione
Veeva Systems Inc Borsa (VEEV) Ultime notizie
Life Science Data Needs an Upgrade: Veeva Has Answers - Fierce Pharma
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock - MSN
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? - Yahoo Finance
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next - The Motley Fool
Veeva Systems: Substantially Overvalued As Growth Slows (NYSE:VEEV) - Seeking Alpha
Veeva Systems (NYSE:VEEV) Partners With Flatiron To Enhance Clinical Trial Data Efficiency - Yahoo Finance
Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
Q4 Earnings Outperformers: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Stocks - Yahoo Finance
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Veeva Systems’ chief customer officer sells $265,168 in stock By Investing.com - Investing.com India
Veeva Systems’ chief customer officer sells $265,168 in stock - Investing.com
4 Ways Top Sponsors Build Strong and Sustainable Site Relationships - Veeva
Investors Interested In Veeva Systems Inc.'s (NYSE:VEEV) Earnings - simplywall.st
Improve Safety Outputs, Oversight, and Data Quality with In-house Pharmacovigilance Solution - Veeva
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? - Nasdaq
eClinical Solutions Market Top PlayersMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
ACELYRIN Optimizes the Sponsor-CRO Data Flow with a Centralized Clinical Data Workbench - Veeva
Veeva Systems director Timothy Cabral sells $841,734 in stock By Investing.com - Investing.com Canada
Veeva Systems director Timothy Cabral sells $841,734 in stock - Investing.com
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know - Yahoo Finance
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? - Yahoo Finance
Veeva Systems (VEEV) Benefited in Q4 From Strong Execution - Insider Monkey
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Best Momentum Stocks to Buy for April 3rd - TradingView
Veeva Systems Inc. (NYSE:VEEV) Receives $256.52 Average PT from Brokerages - MarketBeat
Veeva Systems SVP sells shares worth $178,019 - Investing.com Australia
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It? - MSN
Veeva Systems SVP sells shares worth $178,019 By Investing.com - Investing.com Canada
We Think Veeva Systems' (NYSE:VEEV) Profit Is Only A Baseline For What They Can Achieve - Yahoo
VEEV Stock Slips Despite New Research Site Clinical Trial System - Yahoo Finance
How UCB and Other Biopharmas Made the Case for Safety Transformation - Veeva
Aligning Medical & Commercial Teams to Drive Product Adoption - Veeva
Veeva Systems (NYSE:VEEV) Unveils New CTMS for Efficient Clinical Trial Management - Yahoo Finance
Veeva Announces Research Site Clinical Trial Management System - Contract Pharma
5 Momentum Stocks to Buy for April Despite a Disappointing March - TradingView
Sell Rating for Veeva Systems Amid Volatile Macroeconomic Conditions and Industry Risks - TipRanks
EVERSANA joins with Veeva in push to 'pharmatise AI' - pharmaphorum
EVERSANA Joins Veeva AI Partner Program - PR Newswire
Top Stock Picks for Week of March 31, 2025 - TradingView
Veeva Systems’ SWOT analysis: cloud software leader faces industry headwinds - Investing.com
Here's Why You Should Add Veeva Systems Stock to Your Portfolio Now - MSN
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market - Investor's Business Daily
What Does the Market Think About Veeva Systems? - Benzinga
Verve: Embracing Digital-First Quality - Veeva
Exponential Growth Expected for Clinical Data Management - openPR
Veeva Systems, Inc. is hiring: Creative Operations Manager in New York - Mediabistro
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):